| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 103.817.953 $ | 99,39 | 1.251.090 | |||||||
| Eli Lilly & Co | Eli Lilly & Co | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 12.625.683 $ | 12,09 | 13.727 | |
| Merck & Co Inc | Merck & Co Inc | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 7.012.306 $ | 6,71 | 58.295 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 6.315.352 $ | 6,05 | 25.836 | |
| UnitedHealth Group Inc | UnitedHealth Group Inc | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 4.296.969 $ | 4,11 | 15.880 | |
| Intuitive Surgical Inc | Intuitive Surgical Inc | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 3.691.608 $ | 3,53 | 8.008 | |
| AbbVie Inc | AbbVie Inc | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 3.328.902 $ | 3,19 | 15.306 | |
| Abbott Laboratories | Abbott Laboratories | EC | 002824100 | Long | Börsenkurs (Stufe 1) | 3.010.592 $ | 2,88 | 29.323 | |
| Danaher Corp | Danaher Corp | EC | 235851102 | Long | Börsenkurs (Stufe 1) | 2.962.500 $ | 2,84 | 15.625 | |
| Edwards Lifesciences Corp | Edwards Lifesciences Corp | EC | 28176E108 | Long | Börsenkurs (Stufe 1) | 2.851.809 $ | 2,73 | 35.612 | |
| Vertex Pharmaceuticals Inc | Vertex Pharmaceuticals Inc | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 2.613.599 $ | 2,50 | 5.853 | |
| Boston Scientific Corp | Boston Scientific Corp | EC | 101137107 | Long | Börsenkurs (Stufe 1) | 2.312.840 $ | 2,21 | 36.858 | |
| CVS Health Corp | CVS Health Corp | EC | 126650100 | Long | Börsenkurs (Stufe 1) | 2.190.079 $ | 2,10 | 30.494 | |
| Cencora Inc | Cencora Inc | EC | 03073E105 | Long | Börsenkurs (Stufe 1) | 2.060.130 $ | 1,97 | 6.558 | |
| Regeneron Pharmaceuticals Inc | Regeneron Pharmaceuticals Inc | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 1.954.007 $ | 1,87 | 2.529 | |
| HCA Healthcare Inc | HCA Healthcare Inc | EC | 40412C101 | Long | Börsenkurs (Stufe 1) | 1.940.757 $ | 1,86 | 4.101 | |
| Thermo Fisher Scientific Inc | Thermo Fisher Scientific Inc | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 1.781.305 $ | 1,71 | 3.624 | |
| Elevance Health Inc | Elevance Health Inc | EC | 036752103 | Long | Börsenkurs (Stufe 1) | 1.668.090 $ | 1,60 | 5.698 | |
| Medtronic PLC | Medtronic PLC | EC | IE00BTN1Y115 | Long | Börsenkurs (Stufe 1) | 1.514.989 $ | 1,45 | 17.484 | |
| Cardinal Health Inc | Cardinal Health Inc | EC | 14149Y108 | Long | Börsenkurs (Stufe 1) | 1.451.277 $ | 1,39 | 6.868 | |
| GSK PLC | GSK PLC | EC | GB00BN7SWP63 | Long | Modellwert (Stufe 2) | 1.420.961 $ | 1,36 | 51.586 | |
| Agilent Technologies Inc | Agilent Technologies Inc | EC | 00846U101 | Long | Börsenkurs (Stufe 1) | 1.309.744 $ | 1,25 | 11.491 | |
| United Therapeutics Corp | United Therapeutics Corp | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 1.289.139 $ | 1,23 | 2.174 | |
| Stryker Corp | Stryker Corp | EC | 863667101 | Long | Börsenkurs (Stufe 1) | 1.175.695 $ | 1,13 | 3.578 | |
| Argenx SE | Argenx SE | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 1.116.552 $ | 1,07 | 1.529 | |
| UCB SA | UCB SA | EC | BE0003739530 | Long | Modellwert (Stufe 2) | 1.095.816 $ | 1,05 | 3.637 | |
| Dexcom Inc | Dexcom Inc | EC | 252131107 | Long | Börsenkurs (Stufe 1) | 1.059.687 $ | 1,01 | 16.874 | |
| Biogen Inc | Biogen Inc | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 1.004.832 $ | 0,96 | 5.481 | |
| Apellis Pharmaceuticals Inc | Apellis Pharmaceuticals Inc | EC | 03753U106 | Long | Börsenkurs (Stufe 1) | 950.957 $ | 0,91 | 23.638 | |
| STERIS PLC | STERIS PLC | EC | IE00BFY8C754 | Long | Börsenkurs (Stufe 1) | 894.029 $ | 0,86 | 4.043 | |
| Ionis Pharmaceuticals Inc | Ionis Pharmaceuticals Inc | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 843.786 $ | 0,81 | 11.237 | |
| Incyte Corp | Incyte Corp | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 822.891 $ | 0,79 | 8.743 | |
| Alnylam Pharmaceuticals Inc | Alnylam Pharmaceuticals Inc | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 815.264 $ | 0,78 | 2.464 | |
| Madrigal Pharmaceuticals Inc | Madrigal Pharmaceuticals Inc | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 804.050 $ | 0,77 | 1.536 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | 04351P101 | Long | Börsenkurs (Stufe 1) | 791.406 $ | 0,76 | 3.460 | |
| Bristol-Myers Squibb Co | Bristol-Myers Squibb Co | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 777.048 $ | 0,74 | 12.812 | |
| Elanco Animal Health Inc | Elanco Animal Health Inc | EC | 28414H103 | Long | Börsenkurs (Stufe 1) | 741.926 $ | 0,71 | 31.004 | |
| Galderma Group AG | Galderma Group AG | EC | CH1335392721 | Long | Modellwert (Stufe 2) | 726.192 $ | 0,70 | 3.695 | |
| Cytokinetics Inc | Cytokinetics Inc | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 712.817 $ | 0,68 | 10.815 | |
| Encompass Health Corp | Encompass Health Corp | EC | 29261A100 | Long | Börsenkurs (Stufe 1) | 671.596 $ | 0,64 | 6.943 | |
| Protagonist Therapeutics Inc | Protagonist Therapeutics Inc | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 665.812 $ | 0,64 | 6.317 | |
| Revolution Medicines Inc | Revolution Medicines Inc | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 643.017 $ | 0,62 | 6.612 | |
| Bio-Techne Corp | Bio-Techne Corp | EC | 09073M104 | Long | Börsenkurs (Stufe 1) | 627.538 $ | 0,60 | 12.008 | |
| Disc Medicine Inc | Disc Medicine Inc | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 609.796 $ | 0,58 | 9.537 | |
| Alignment Healthcare Inc | Alignment Healthcare Inc | EC | 01625V104 | Long | Börsenkurs (Stufe 1) | 608.313 $ | 0,58 | 34.524 | |
| Pharvaris NV | Pharvaris NV | EC | NL00150005Y4 | Long | Börsenkurs (Stufe 1) | 598.787 $ | 0,57 | 21.196 | |
| HeartFlow Inc | HeartFlow Inc | EC | 42238D107 | Long | Börsenkurs (Stufe 1) | 591.511 $ | 0,57 | 24.312 | |
| Option Care Health Inc | Option Care Health Inc | EC | 68404L201 | Long | Börsenkurs (Stufe 1) | 548.980 $ | 0,53 | 20.393 | |
| Scholar Rock Holding Corp | Scholar Rock Holding Corp | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 534.074 $ | 0,51 | 10.864 | |
| ICON PLC | ICON PLC | EC | IE0005711209 | Long | Börsenkurs (Stufe 1) | 532.607 $ | 0,51 | 4.813 | |
| Apogee Therapeutics Inc | Apogee Therapeutics Inc | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 525.473 $ | 0,50 | 6.243 | |
| Avantor Inc | Avantor Inc | EC | 05352A100 | Long | Börsenkurs (Stufe 1) | 517.534 $ | 0,50 | 66.012 | |
| Dianthus Therapeutics Inc | Dianthus Therapeutics Inc | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 514.094 $ | 0,49 | 6.126 | |
| Kymera Therapeutics Inc | Kymera Therapeutics Inc | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 502.988 $ | 0,48 | 6.039 | |
| PTC Therapeutics Inc | PTC Therapeutics Inc | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 502.050 $ | 0,48 | 7.369 | |
| Mirum Pharmaceuticals Inc | Mirum Pharmaceuticals Inc | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 498.760 $ | 0,48 | 5.399 | |
| Structure Therapeutics Inc | Structure Therapeutics Inc | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 488.411 $ | 0,47 | 10.133 | |
| Arcus Biosciences Inc | Arcus Biosciences Inc | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 485.849 $ | 0,47 | 22.493 | |
| Natera Inc | Natera Inc | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 478.776 $ | 0,46 | 2.394 | |
| Viridian Therapeutics Inc | Viridian Therapeutics Inc | EC | 92790C104 | Long | Börsenkurs (Stufe 1) | 477.068 $ | 0,46 | 24.390 | |
| QIAGEN NV | QIAGEN NV | EC | NL0015002SN0 | Long | Börsenkurs (Stufe 1) | 475.275 $ | 0,46 | 11.870 | |
| Oculis Holding AG | Oculis Holding AG | EC | CH1242303498 | Long | Börsenkurs (Stufe 1) | 463.783 $ | 0,44 | 17.442 | |
| Xenon Pharmaceuticals Inc | Xenon Pharmaceuticals Inc | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 443.336 $ | 0,42 | 7.624 | |
| Acadia Healthcare Co Inc | Acadia Healthcare Co Inc | EC | 00404A109 | Long | Börsenkurs (Stufe 1) | 434.422 $ | 0,42 | 18.573 | |
| Adaptive Biotechnologies Corp | Adaptive Biotechnologies Corp | EC | 00650F109 | Long | Börsenkurs (Stufe 1) | 428.351 $ | 0,41 | 30.861 | |
| AstraZeneca PLC | AstraZeneca PLC | EC | GB0009895292 | Long | Börsenkurs (Stufe 1) | 427.376 $ | 0,41 | 2.167 | |
| Nuvalent Inc | Nuvalent Inc | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 420.352 $ | 0,40 | 4.103 | |
| Celldex Therapeutics Inc | Celldex Therapeutics Inc | EC | 15117B202 | Long | Börsenkurs (Stufe 1) | 398.689 $ | 0,38 | 12.569 | |
| Vaxcyte Inc | Vaxcyte Inc | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 397.472 $ | 0,38 | 6.840 | |
| Mineralys Therapeutics Inc | Mineralys Therapeutics Inc | EC | 603170101 | Long | Börsenkurs (Stufe 1) | 390.665 $ | 0,37 | 14.421 | |
| Soleno Therapeutics Inc | Soleno Therapeutics Inc | EC | 834203309 | Long | Börsenkurs (Stufe 1) | 390.310 $ | 0,37 | 11.658 | |
| GenFleet Therapeutics Shanghai Inc | GenFleet Therapeutics Shanghai Inc | EC | CNE1000074L2 | Long | Börsenkurs (Stufe 1) | 389.556 $ | 0,37 | 91.400 | |
| Inspire Medical Systems Inc | Inspire Medical Systems Inc | EC | 457730109 | Long | Börsenkurs (Stufe 1) | 383.343 $ | 0,37 | 7.432 | |
| Jiangsu Hengrui Pharmaceuticals Co Ltd | Jiangsu Hengrui Pharmaceuticals Co Ltd | EC | CNE100006XS6 | Long | Modellwert (Stufe 2) | 380.728 $ | 0,36 | 45.725 | |
| Immunocore Holdings PLC | Immunocore Holdings PLC | EC | 45258D105 | Long | Börsenkurs (Stufe 1) | 365.569 $ | 0,35 | 12.125 | |
| Immunome Inc | Immunome Inc | EC | 45257U108 | Long | Börsenkurs (Stufe 1) | 362.801 $ | 0,35 | 16.589 | |
| Stoke Therapeutics Inc | Stoke Therapeutics Inc | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 352.950 $ | 0,34 | 10.840 | |
| Trevi Therapeutics Inc | Trevi Therapeutics Inc | EC | 89532M101 | Long | Börsenkurs (Stufe 1) | 345.075 $ | 0,33 | 28.925 | |
| Crinetics Pharmaceuticals Inc | Crinetics Pharmaceuticals Inc | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 295.717 $ | 0,28 | 8.142 | |
| Aktis Oncology Inc | Aktis Oncology Inc | EC | 01021M104 | Long | Börsenkurs (Stufe 1) | 259.995 $ | 0,25 | 14.533 | |
| Newamsterdam Pharma Co NV | Newamsterdam Pharma Co NV | EC | NL00150012L7 | Long | Börsenkurs (Stufe 1) | 245.933 $ | 0,24 | 7.683 | |
| CG oncology Inc | CG oncology Inc | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 126.900 $ | 0,12 | 1.875 | |
| Corvus Pharmaceuticals Inc | Corvus Pharmaceuticals Inc | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 58.520 $ | 0,06 | 4.000 | |
| Eikon Therapeutics Inc | Eikon Therapeutics Inc | EC | 282564103 | Long | Börsenkurs (Stufe 1) | 22.218 $ | 0,02 | 2.100 | |
| 103.817.953 $ | 99,39 | 1.251.090 |